jnadeau

I just answered this question. My Score PASS  

I take plasma from group O patient samples (no longer needed) who have a negative antibody screen and add about 2 ul of antisera per 2 ml of plasma. This usually will give 2-3+ reactions in gel (but as Cliff said it doesn't always act as expected). I use expired 3% panel cells, negative for the antibody I spiked the plasma with, for them to use as a "patient".

My guess would be that Ortho asked the FDA to delist - to sell more units. I'm now using a tube incubator that is older than me (well almost) until the new one arrives.

We call them "Alerts" - new hemolytic antibody identified during pregnancy, pos DAT on baby, transfusion error or serious trx, no compatible units for a specific patient or delay of product. It's called and documented in the computer.

I believe the 4C thio is for isolation of Yersinia - likes the cold - but I haven't worked microbiology in many years now. There's a special media micro uses for that now - I think.

Thank you very much Malcolm - you're the best! If you would clarify in the second paragraph please - worth their salt "would" or "would not" report out... we're filled with Canadian smoke here and it may be causing me confusion

Is anyone using the phrase "No antibodies detected" in resulting an antibody screen? I know "Negative" is commonly used but I remember using NAD someplace in the past - and seeing it through the years. Just thinking that it is clinically more truthful than a flat out NEG result. All detection methods have their caveats and can miss some patient antibodies - manufacturers have disclaimers in their IFUs. Maybe the patient's antibody is below detection with the method. Could also avoid finger pointing by the provider (or worse - a lawyer in a malpractice suit) if a patient DID have complications (or worse) and they were recently transfused. Some reference labs result as NEG for the serum studies but then it goes on with the Additional Comments - all clinically significant alloantibodies have been rules out using etc.

No Dr. Blumberg - not the transfusion rate - the dialysis access flow rate evidently needs to be adequate to do the dialysis and also add in blood using an infusion pump as usual. The SOP (which is not mine) states a start rate of 75 ml/hr for the first 15 min, if vital signs are within normal limits/pt's baseline, adjust over 45 min and transfuse the remaining blood product within ONE hour". This is unfortunately coming to the blood bank because anything with blood product infusion (and reinfusion) stumbles into our purview - e.g. cell saver, nuclear med reinfusions.

Does anyone have a caution statement in their Blood Administration Procedure to "assure patient's hemodialysis access has blood flows > or = 300 ml/min before requesting any blood products from the Blood Bank? Many dialysis patients don't have that level of blood flow. What will transfusing blood with less flow do to the patient's access (or the transfusing blood)?

We keep the opened segment used for the crossmatch instead of pulling segs on receipt or issue of units. I've done that at other facilities - seemed like just another thing to store and then toss. When a TRX is called it's easy to pull the sample with the segs used (rubber banded to sample), do the clerical check (match up the segment DIN and the seg # with #'s on the returned bag) and then get a couple more drops out of the seg for testing. Have never run out of cells and can "confirm" the right seg was used for the crossmatch.

Cliff - can't we keep the lightbulbs to bust up until this allocation is over? It's very therapeutic.

Meeting title is type O Allocation Initiative

Our ARC rep has a meeting set up for the blood bank sups in our affiliation for this afternoon - 12/08/21 - we're in NY so it's not just your region Mabel.

Yes we have too. Try Vista if MLA is backordered in your region.

"Compatible blood for a corpse is not a triumph" (sorry - forgot who to attribute this to)